A Study in Moderate to Severe Rheumatoid Arthritis Participants

Clinical trial NCT01721057 · COMPLETED

Trial details

NCT number: NCT01721057
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2012-12-01
Primary completion: 2014-09-01
Enrollment: 684

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.